Results Copy number of the miRNAs measured by digital PCR displayed a linear response to input cDNA amount in a twofold dilution series over seven orders of magnitude. miRNA quantification determined by digital PCR assay was in good agreement with that obtained from qRT-PCR analysis in sputum. Furthermore, combined quantification of miR-31 and miR-210 copy number by using digital PCR in sputum of the cases and controls provided 65.71 % sensitivity and 85.00 % specificity for lung cancer diagnosis. Conclusion As digital PCR becomes more established, it would be a robust tool for quantitative assessment of miRNA copy number in sputum for lung cancer diagnosis.
Introduction
Lung cancer is responsible for 29 % of cancer deaths, causing more deaths than breast cancer, colon cancer, and prostate cancer combined (Siegel et al. 2013) . Approximately, 85 % of lung cancers are non-small-cell lung cancer (NSCLC). The early detection of NSCLC followed by suitable treatments can reduce lung cancer-related deaths (Aberle et al. 2011; Greenlee et al. 2001; Siegel et al. 2013) . Sputum is one of the most noninvasively accessible body fluids and contains exfoliated airway epithelial cells (Thunnissen 2003) . Molecular analysis of sputum can indicate the specific source of the abnormal cells in the lungs, thus providing a noninvasive and organ-specific diagnostic approach for lung cancer (Thunnissen 2003) . MicroRNAs (miRNAs) contribute to the regulation of key cellular processes, including cellular development, differentiation, proliferation, cell death, and metabolism (Ambros 2003) . The 1 3 dysregulation of miRNAs has important roles in tumor initiation and progression (Galasso et al. 2010; Lu et al. 2005) . miRNA expression profiles offer molecular signatures for the classification, diagnosis, and progression of cancer, and thus could be developed as cancer biomarkers (Lu et al. 2005; Shen et al. 2011a Shen et al. , b, 2013a Shen and Jiang 2012; Yanaihara et al. 2006) . We previously showed that miRNAs were stably present in sputum and reliably measurable by using quantitative reverse transcriptase PCR (qRT-PCR) assay (Anjuman et al. 2013; Xie et al. 2010; Xing et al. 2010; Yu et al. 2010) . We recently found that combined analysis of two miRNAs (miR-31 and miR-210) in sputum using qRT-PCR could yield 65.2 % sensitivity and 89.7 % specificity for lung cancer diagnosis (Fan et al. 2007) .
Droplet digital PCR is a direct method for quantitatively measuring nucleic acids and more sensitive in resolving copy number changes of DNA and RNA targets compared to qRT-PCR (Day et al. 2013; Vogelstein and Kinzler 1999) . In this study, we evaluated dynamic range of digital PCR for miRNA quantification in sputum and investigated its potential to be used as a tool for lung cancer diagnosis. This study presents the earliest assessment of digital PCR as a viable means for quantitative detection of miRNAs in sputum for lung cancer diagnosis.
Materials and methods

Subjects and sputum collection and preparation
This study was performed under a protocol approved by the Institutional Review Board of University of Maryland Baltimore. Written informed consent was obtained from all enrolled subjects: 35 stage I NSCLC patients and 40 cancer-free smokers. Geographic and clinical characteristics of the cases and controls are shown in Table 1 . The 35 eligible cancer patients were stage I NSCLC patients before receiving surgical treatment, preoperative adjuvant chemotherapy, and radiotherapy. Inclusion criteria for cancer-free controls were individuals who had no a history of cancer in the last 3 years at the time of enrolment. Clinical diagnosis of lung cancer was made with histopathological examinations of specimens obtained by CT-guided transthoracic needle biopsy, transbronchial biopsy, videotapeassisted thoracoscopic surgery, or surgical resection. The surgical pathologic staging was determined according to the TNM classification of the International Union Against Cancer with the American Joint Committee on Cancer and the International Staging System for Lung Cancer. Histopathological classification was determined according to the World Health Organization classification.
Sputum was collected from the participants as described in our previous reports (Anjuman et al. 2013; Jiang et al. 2009 Jiang et al. , 2010 Li et al. 2007; Qiu et al. 2008; Xie et al. 2010; Xing et al. 2010; Yu et al. 2010) . The samples were processed on ice in four volumes of 0.1 % dithiothreitol (Sigma-Aldrich Corporation, St. Louis, MO, USA), and the mixture was vortexed for 15 min. A double volume of a phosphate-buffered saline solution was then added, and the mixture was briefly vortexed. After filtration through two layers of a sterile gauze to remove mucous and debris, sputum was centrifuged for 10 min at 800×g. The cell pellet was resuspended in a phosphate-buffered saline solution. miRNA quantification in sputum by using digital PCR and qRT-PCR Total RNA from the cell pellets of sputum was purified by using miRVana™ PARIS™ Kit (Ambion, Austin, TX, USA) as described in our previous reports (Fan et al. 2007; Shen et al. 2011a, b; Xie et al. 2010; Xing et al. 2010; Yu et al. 2010) . The qualification and quantification of RNA were assessed by using Biospectrometer (Hutchinson Technology Inc., Hutchinson, MN, USA) and Electrophoresis Bioanalyzer (Agilent Technologies, Foster City, CA, USA). cDNA was reversely transcribed from 100 ng RNA using miRNA-specific primers for miR-31 and 210 in 15 μl reaction mixture, respectively. Digital PCR was performed in the samples as previously described (Heredia et al. 2013; Hindson et al. 2011 Hindson et al. , 2013 . Briefly, TaqMan™ reaction mix containing sample cDNA was partitioned into aqueous Conventional qRT-PCR analysis was performed as described in our previous reports (Shen et al. 2011a , b, Xie et al. 2010 Xing et al. 2010; Yu et al. 2010) . Briefly, cDNA was combined with PCR reagents to produce a PCR reaction in a total volume of 5.0 μl. qPCR was carried out on an Applied BioSystems 7900HT thermocycler (Bio-Rad) at 95 °C for 10 min, followed by 40 cycles of 95 °C for 15 s and 60 °C for 1 min. qPCR data were analyzed by using BioRad's manager software (Bio-Rad) with automatic threshold cycle (C t ) setting for assigning baseline and threshold for C t determination. C t values of the miRNAs were normalized in relation to that of U6. All assays were performed in triplicates, and one no-template control and two interplate controls were carried along in each experiment.
Statistical analysis
We used t test to determine significant differences of values between groups. We applied Pearson's correlation analysis to assess relationship between copy number of the miRNAs and demographic characteristics of the patients and cancerfree controls. We used Kappa statistics to evaluate agreement between the different individuals for quantification of miRNAs. We used clinicopathologic diagnoses as reference standards to estimate sensitivity and specificity of the miRNAs. We applied the receiver-operator characteristic (ROC) curve and area under the curve (AUC) analyses to determine the accuracy of each miRNA in a specimen. All P values shown were two-sided, and a P value of <0.05 was considered statistically significant.
Results
A dynamic range of digital PCR for miRNA quantification in sputum
To determine performance characteristics of digital PCR for the assessment of miRNAs in sputum, cDNA was transcribed from RNA of cellular pellets of sputum obtained from five healthy individuals who were nonsmokers. The generated cDNA was then diluted by twofold across seven orders of magnitude ranging from 1:8 to 1:512. The serially diluted samples were run for quantification of miR-31 and miR-210 by using digital PCR. As shown in Fig. 1a , each well of the samples contained at least 10,000 droplets, implying that the specimens could be successfully "read" by passing the droplets through a fluorescence detector. There was excellent linearity between the cDNA input and values measured by digital PCR across seven orders of magnitude for the miRNA targets (Fig. 1b, c) . To determine reproducibility between digital PCR assays for miRNA quantification, the panel of diluted samples was independently analyzed by two research staff. There was a high agreement between the results created from the independent digital PCR assays (the kappa statistic for concordance was 0.89, P < 0.01). Furthermore, to compare dynamic ranges of digital PCR and qPCR for miRNA quantification in sputum, the serially diluted specimens were also analyzed by using qRT-PCR assay. The relative expression of each miRNA by qRT-PCR was calculated and normalized to U6 using a C t method. As shown in Fig. 1d , there was a good agreement between copy numbers of the miRNAs determined by digital PCR and the expression levels measured by qRT-PCR across the serially diluted samples.
Diagnostic performance of miRNA quantification in sputum by digital PCR
To investigate the potential of using digital PCR for assessment of miRNAs in sputum for lung cancer diagnosis, we evaluated absolute copy number of two miRNAs, miR-31 and miR-210, in a cohort of 35 NSCLC patients and 40 cancer-free subjects. miR-31 and miR-210 were selected, as they were previously identified as potential sputum miRNA biomarkers for lung cancer diagnosis (Anjuman et al. 2013) . Copy number of miR-31 per μl in sputum of cancerfree individuals and lung cancer patients was 73.78 ± 10.81 and 173.2 ± 24.52, respectively (P < 0.01) (Fig. 2a) . Copy number of miR-210 per μl in sputum of cancer-free individuals and lung cancer patients was 303.6 ± 34.14 and 737.8 ± 100.00, respectively (P < 0.01) (Fig. 2b) . Overall, both miR-31 and miR-210 had significantly higher copy number in sputum of lung cancer patients compared with cancer-free controls. Furthermore, assaying copy number of the two individual miRNAs generated AUC value of 0.75 and 0.73, respectively, in distinguishing NSCLC patients from the controls (Fig. 3a, b) . Combined quantification of the two miRNAs yielded 0.86 AUC that was statistically higher than that of individual one used alone (Fig. 3c ) (all P < 0.05). Given a specificity of 85.00 %, the two miRNAs used in conjunction revealed a sensitivity of 65.71 % in differentiating NSCLC patients from the cancer-free subjects. The prevalence of the miRNA copy number in sputum was related with pack-years of smoking (P < 0.05), however, not associated with patient age, gender, histological tumor type and stage, and location of the tumors (all P > 0.05).
Discussion
qRT-PCR uses Ct as a metric for analysis of miRNA expression levels, in which Ct values for miRNA targets are referenced to endogenous small RNA controls across samples and used for normalization. However, expression levels of the endogenous controls and their transcripts may differ between samples (Dodd et al. 2013; Whale et al. 2012) . Therefore, qRT-PCR is an indirect method for analysis of RNA targets and does not provide exact quantitation of miRNAs.
Digital PCR is a direct method for absolute nucleic acid quantification based on the partitioning of individual analyte molecules into many replicate reactions at limiting dilution, resulting in one or zero molecules in most reactions (Day et al. 2013; Vogelstein and Kinzler 1999) . After endpoint PCR, the starting concentration of template is determined by Poisson statistical analysis of the number Fig. 1 The dynamic range of digital PCR for miR-31 quantification in sputum of healthy individuals. The generated cDNA was diluted by twofold across seven orders of magnitude ranging from 1:8 to 1:512 and run for miRNA quantification by using digital PCR. a Each well of the samples and a negative template control (NTC) sample contained at least 10,000 droplets, suggesting that sputum could successfully be analyzed by digital PCR. of positive (containing amplified target) and negative (no amplified target detected) reactions (Day et al. 2013; Vogelstein and Kinzler 1999) . Thus, notable benefits of digital PCR over qPCR are the capability to obtain absolute quantification without external references and robustness to variations in PCR efficiency. Herein, we find that each well of each sputum sample contains at least 10,000 droplets, and digital PCR produces a direct, high-confidence measurement of the original target miRNA concentration. Furthermore, rapid analysis of at least 10,000 of droplets per sputum indicates that absolute quantification of miRNA copy number by digital PCR is highly efficient. In addition, the digital nature of the results means that data handling is relatively straightforward. Therefore, digital PCR would overcome the weakness of the conventional qRT-PCR technique for absolute assessment of miRNAs in sputum.
Our head-to-head comparison of digital PCR and qRT-PCR in the same set of specimens reveals a good agreement between copy numbers of the miRNAs by digital PCR and the expression levels by qRT-PCR. Furthermore, digital PCR displays a high reproducibility in measuring copy number of the sputum miRNAs. In addition, the combed analysis of the two miRNAs by digital PCR offers higher sensitivity and specificity for lung cancer diagnosis compared with a single one used alone. Altogether, digital PCR could provide a viable means for absolute quantification of miRNAs in sputum whose changes are the hallmarks of lung cancer. This is a pilot study to investigate the feasibility of using digital PCR for miRNA quantification in sputum, as such some limitations exist. First, the sample size is small. Second, the sensitivity (65.71 %) and specificity (85.00 %) by quantifying the two miRNAs are not efficient for diagnosis of NSCLC. In our ongoing project, we are evaluating digital PCR for sputum miRNA quantification in large cohort of cases and controls. We are also analyzing more lung tumor-associated miRNAs defined from our and others' groups (Shen et al. 2011a (Shen et al. , b, 2013a Yanaihara et al. 2006 ) to identify additional sputum-based miRNA biomarkers that can be added to the current ones, so that the diagnostic efficacy of digital PCR could be improved.
Conclusion
This work demonstrates that digital PCR can absolutely quantify copy number of miRNAs and potentially provide a viable means for the detection of sputum miRNAs for lung cancer diagnosis. Nonetheless, the continued development of this new technology and further exploring its value for routine use in diagnostic testing for lung cancer would be required. Fig. 3 Diagnostic values of miRNA quantification by digital PCR in sputum. a Receiver-operator characteristic (ROC) curve analysis of copy numbers of the miR-31 in sputum of the 35 lung cancer patients and 40 cancer-free individuals. The area under the ROC curve (AUC) for each miRNA conveyed its accuracy in differentiating lung cancer patients from the control subjects with respect to sensitivity and specificity. miR-31 produced 0.75 AUC value. b miR-210 produced 0.73 AUC value. c Combined quantification of miR-31 and miR-210 by digital PCR produced 0.86 AUC that was statistically higher than that of individual one used alone
